Key result
Immune cells emerge as promising therapeutic targets in cardiovascular diseases.
Why the study?
The functions of the immune system in cardiovascular diseases have historically been under-appreciated, partly due to the difficulty of detecting immune cells within the living human cardiovascular system.
Answers are grounded in this paper and cite their sources.
The immune system plays a complex and essential role in both normal cardiac function and the pathogenesis of cardiovascular diseases, making immune cells promising therapeutic targets.
The cells of the immune system have a myriad of roles in the prevention, development, maintenance and resolution of numerous cardiovascular diseases (1). These functions have historically been under-appreciated, in part due to the difficulty of detecting immune cells within the living human cardiovascular system. We now appreciate that all major immune cell classes are present in healthy mouse hearts (2) and that certain immune cell populations are essential for aspects of normal cardiac function including normal electrical activation (3). The immune system and the heart thus have a complex interaction in both steady state and perturbations of this steady state in disease (4). The consequences of immune responses in the heart can range from the essentially undetectable to myocyte loss and the development of fibrosis, heart failure, arrhythmia and death. Immune cells and their roles within the cardiovascular system are now a major focus of interest and are promising therapeutic targets (5,6).
No takes yet. Share an insight, caveat, or question.
Lewis et al. (2020) conducted a review in Inflammatory heart diseases. Immune cells play essential roles in normal cardiac function and disease pathogenesis, making them promising therapeutic targets in cardiovascular diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: